Brief: PROCEPT BioRobotics Corp Reports Aetna and Independence Blue Cross Blue Shield Positive Coverage Decisions Regarding Aquablation Therapy
28/04/2022 13:25
April 28 (Reuters) - Procept Biorobotics Corp PRCT.O :
* PROCEPT BIOROBOTICS CORP ANNOUNCES AETNA & INDEPENDENCE
BLUE
CROSS BLUE SHIELD POSITIVE COVERAGE DECISIONS REGARDING
AQUABLATION THERAPY FOR MEN WITH ENLARGED PROSTATES
Source text for Eikon: ID:nGNXbsSTg4
Further company coverage: PRCT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PROCEPT BioRobotics
See all newsU.S. STOCKS ON THE MOVE -VF Corp, Biogen, AbbVie
US STOCKS ON THE MOVE-SpaceX, Humana, AbbVie
U.S. STOCKS ON THE MOVE-SpaceX, Humana, Crescent Energy
MedTech growth concerns likely to overshadow Q3 results, Leerink says
Brief: Procept Biorobotics Corporation Enters Third Amendment To Loan And Security Agreement With Cibc